Sophia Genetics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH)
RBC Capital Remains a Buy on SOPHiA GENETICS (SOPH)
SOPHiA GENETICS (SOPH) Gets a Buy From RBC Capital
RBC Capital Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)
Sophia Genetics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH), Green Thumb Industries (OtherGTBIF) and Marinus (MRNS)
Buy Rating Affirmed for SOPHiA GENETICS Amid Growth and Market Expansion Potential
TD Cowen Remains a Buy on SOPHiA GENETICS (SOPH)
RBC Capital Remains a Buy on SOPHiA GENETICS (SOPH)
Sophia Genetics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Genmab (GMAB), SOPHiA GENETICS (SOPH)
BTIG Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)
RBC Capital Initiates Coverage On Sophia Genetics With Outperform Rating, Announces Price Target of $8
Sophia Genetics Analyst Ratings
Strong Revenue Growth and New Partnerships Bolster SOPHiA GENETICS' Buy Rating: An Analysis of Mark Massaro's Recommendation
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH), Calliditas Therapeutics (CALT) and Ascend Wellness Holdings LLC (OtherAAWH)
J.P. Morgan Remains a Buy on SOPHiA GENETICS (SOPH)
BTIG Keeps Their Buy Rating on SOPHiA GENETICS (SOPH)
Credit Suisse Maintains Neutral on Sophia Genetics, Raises Price Target to $5